Bio-Rad Laboratories, Inc. (BIO) Financials
BIO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 12.3 billion | 3.6 billion |
2023-09-30 | 11.9 billion | 3.5 billion |
2023-06-30 | 12.0 billion | 3.5 billion |
2023-03-31 | 13.7 billion | 3.9 billion |
BIO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 38.8 million | 16.2 million |
2023-09-30 | 53.6 million | 15.9 million |
2023-06-30 | 63.4 million | 12.6 million |
2023-03-31 | 62.4 million | 16.6 million |
BIO Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 349.7 million |
2023-09-30 | 106.3 million |
2023-06-30 | -1.2 billion |
2023-03-31 | 69.0 million |
BIO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 1.6 billion | - | 205.9 million |
2023-09-30 | 1.8 billion | 1.2 billion | 216.5 million |
2023-06-30 | 1.7 billion | 1.2 billion | 183.4 million |
2023-03-31 | 1.9 billion | 1.2 billion | 183.2 million |
BIO Shares Outstanding
BIO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 42.2 million | 62.2 million | 207.1 million | - |
2023-09-30 | 44.1 million | 43.5 million | 201.2 million | - |
2023-06-30 | 34.6 million | 65.0 million | 207.8 million | - |
2023-03-31 | 35.7 million | 75.0 million | 225.6 million | - |
BIO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 681.2 million | 315.3 million |
2023-09-30 | 632.1 million | 296.4 million |
2023-06-30 | 681.1 million | 318.6 million |
2023-03-31 | 676.8 million | 314.4 million |
BIO
Price: $279.31
52 week price:
Earnings Per Share: -21.81 USD
P/E Ratio: -54.70
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 92800
Ebitda: 79.8 millionMarket Capitalization: 8.8 billion